Drug · DIN 02267225
MACUGEN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since September 4, 2014; first marketed August 26, 2005.
- Drug Identification Number (DIN)
- 02267225
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravitreal
- Therapeutic class (ATC)
- Pegaptanib S01LA03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PEGAPTANIB | 0.3 MG | 90 MCL |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 2, 2005: NOC 6645New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “macugen”. A notice may cover another product or only some lots: read it to see what it covers.